ENDRA Life Sciences- Warrants (12/05/2022) Current Cash

As of the most recent data (June 2026), NDRAW shows a current cash of $1.7M. That compares with $1.8M in the prior-year period — down 3.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NDRAW's current cash is now $1.7M (was $1.8M) — a 3.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether ENDRA Life Sciences- Warrants (12/05/2022) is outperforming or lagging.

Tracking NDRAW's current cash over time shows whether ENDRA Life Sciences- Warrants (12/05/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.7M That compares with $1.8M in the prior-year period — down 3.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has ENDRA Life Sciences- Warrants (12/05/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $1.7M) with ownership activity and broader fundamentals.

ENDRA Life Sciences- Warrants (12/05/2022)'s current cash is $1.7M; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.